| 1 |
35436155 | Adverse Events Associated With Coprescription of Phosphodiesterase Type 5 Inhibitors and Oral Organic Nitrates in Male Patients With Ischemic Heart Disease : A Case-Crossover Study. | 2022 Jun |
3 |
| 2 |
25410225 | Sexual dysfunction in diabetes. | 2014 |
1 |
| 3 |
25452706 | Switching from nitrate therapy to ranolazine in patients with coronary artery disease receiving phosphodiesterase type-5 inhibitors for erectile dysfunction. | 2014 |
1 |
| 4 |
23917809 | Effectiveness and safety of phosphodiesterase 5 inhibitors in patients with cardiovascular disease and hypertension. | 2013 Oct |
1 |
| 5 |
26328121 | The role of phosphodiesterase type-5 inhibitors in treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia. | 2013 Dec |
1 |
| 6 |
20394470 | Co-possession of phosphodiesterase type-5 inhibitors (PDE5-I) with nitrates. | 2010 Jun |
5 |
| 7 |
20587040 | Potentially fatal new trend in performance enhancement: a cautionary note on nitrite. | 2010 Jun 29 |
2 |
| 8 |
17183346 | Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectile dysfunction? | 2007 May-Jun |
2 |
| 9 |
17467673 | Phosphodiesterase regulation of nitric oxide signaling. | 2007 Jul 15 |
1 |
| 10 |
16387564 | Hemodynamic and exercise effects of phosphodiesterase 5 inhibitors. | 2005 Dec 26 |
2 |
| 11 |
16387566 | Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions. | 2005 Dec 26 |
1 |
| 12 |
16387572 | Emergency department considerations regarding erectile dysfunction. | 2005 Dec 26 |
2 |
| 13 |
16422846 | Successful withdrawal of oral long-acting nitrates to facilitate phosphodiesterase type 5 inhibitor use in stable coronary disease patients with erectile dysfunction. | 2005 Jul |
6 |
| 14 |
15115189 | Role of the cardiologist: clinical aspects of managing erectile dysfunction. | 2004 Apr |
1 |
| 15 |
15197447 | [Erectile dysfunction. New drugs with special consideration of the PDE 5 inhibitors]. | 2004 Jul |
1 |
| 16 |
15223851 | Cardiovascular parameter changes in patients with erectile dysfunction using pde-5 inhibitors: a study with sildenafil and vardenafil. | 2004 Jul-Aug |
1 |
| 17 |
15537369 | New treatment options for erectile dysfunction in patients with diabetes mellitus. | 2004 |
1 |
| 18 |
14622500 | Erectile dysfunction in the cardiac patient. | 2003 Dec |
1 |
| 19 |
14642699 | Time course of the interaction between tadalafil and nitrates. | 2003 Nov 19 |
3 |
| 20 |
11351772 | Phosphodiesterase 5 inhibition: effects on the coronary vasculature. | 2001 Apr |
2 |
| 21 |
11137498 | Sex and the patient with cardiovascular risk factors: focus on sildenafil. | 2000 Dec 18 |
1 |